OR WAIT null SECS
May 29, 2024
The Texas facility helps meet the cross-border logistics demand created by nearshoring.
The SSC strives to simply and add efficiencies to the scheduling technology used by the logistics sector.
May 28, 2024
Results from the CORE-001 clinical trial are expected to be presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.
May 24, 2024
The deal grows it pipeline, powered by panCAR programs in autoimmune disease and oncology.
With the acquisition, Merck’s US and Canada life science business aims to further increase its viral vector manufacturing capabilities.
May 23, 2024
The CDMO will run the active pharmaceutical ingredient pilot plant in Sandwich, UK, along with development laboratories.
The deal features felzartamab, an investigational anti-CD38 monoclonal antibody, whose clinical outcomes have shown potential to tackle various immune-mediated diseases.
May 22, 2024
The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.
The decision comes after success during formulation testing with convincing stability data.